Dylan Scott

In vielen Fällen für eine klinische Prüfung wie diese, ist es die pharmazeutische Firma, die den Befehl verweigert. Because they want to get a drug approved so they can eventually sell it. But if we take the longer view, we so desperately need this kind of government-funded research to give us new ideas about how we could better treat all kinds of things, including allergies.

In vielen Fällen für eine klinische Prüfung wie diese, ist es die pharmazeutische Firma, die den Befehl verweigert. Because they want to get a drug approved so they can eventually sell it. But if we take the longer view, we so desperately need this kind of government-funded research to give us new ideas about how we could better treat all kinds of things, including allergies.

In vielen Fällen für eine klinische Prüfung wie diese, ist es die pharmazeutische Firma, die den Befehl verweigert. Because they want to get a drug approved so they can eventually sell it. But if we take the longer view, we so desperately need this kind of government-funded research to give us new ideas about how we could better treat all kinds of things, including allergies.

And my fear would be that maybe not tomorrow, maybe not a year, even five years from now, but ten years from now, suddenly the pipeline for allergy treatments is drying up. Dylan Scott, thank you so much for explaining this to us. Thank you for having me, J.Q.

And my fear would be that maybe not tomorrow, maybe not a year, even five years from now, but ten years from now, suddenly the pipeline for allergy treatments is drying up. Dylan Scott, thank you so much for explaining this to us. Thank you for having me, J.Q.

And my fear would be that maybe not tomorrow, maybe not a year, even five years from now, but ten years from now, suddenly the pipeline for allergy treatments is drying up. Dylan Scott, thank you so much for explaining this to us. Thank you for having me, J.Q.

Yes, Sean, as a millennial who is also a hypochondriac, I regret to inform you that younger people, people under 55, which is usually the definition of an early onset cancer case. are in fact getting cancer more often. There's a little couple of ways to slice it.

Yes, Sean, as a millennial who is also a hypochondriac, I regret to inform you that younger people, people under 55, which is usually the definition of an early onset cancer case. are in fact getting cancer more often. There's a little couple of ways to slice it.

Yes, Sean, as a millennial who is also a hypochondriac, I regret to inform you that younger people, people under 55, which is usually the definition of an early onset cancer case. are in fact getting cancer more often. There's a little couple of ways to slice it.

The Wall Street Journal ran an analysis last year of National Cancer Institute data, and the way they put it was one in five new colorectal cancer patients in the U.S. is under 55, which is twice the rate. that we saw in 1995. There was another study that found that, I think it was between 1990 and 2019, the rates overall of cancer among younger people had increased by 80%.

The Wall Street Journal ran an analysis last year of National Cancer Institute data, and the way they put it was one in five new colorectal cancer patients in the U.S. is under 55, which is twice the rate. that we saw in 1995. There was another study that found that, I think it was between 1990 and 2019, the rates overall of cancer among younger people had increased by 80%.

The Wall Street Journal ran an analysis last year of National Cancer Institute data, and the way they put it was one in five new colorectal cancer patients in the U.S. is under 55, which is twice the rate. that we saw in 1995. There was another study that found that, I think it was between 1990 and 2019, the rates overall of cancer among younger people had increased by 80%.

It seems like no matter how you look at it, and I looked at a variety of studies for my story, cancer rates among young people are increasing, which I don't know about you, I feel like fits with just my observations in the world.

It seems like no matter how you look at it, and I looked at a variety of studies for my story, cancer rates among young people are increasing, which I don't know about you, I feel like fits with just my observations in the world.

It seems like no matter how you look at it, and I looked at a variety of studies for my story, cancer rates among young people are increasing, which I don't know about you, I feel like fits with just my observations in the world.

Yeah, it's definitely something that's built slowly over time. I talked to a guy at Georgetown named John Marshall, and he's been in this field for decades, and he said at the beginning of his career, he never would have seen a cancer patient under the age of 50. But these days, he sees it all the time.

Yeah, it's definitely something that's built slowly over time. I talked to a guy at Georgetown named John Marshall, and he's been in this field for decades, and he said at the beginning of his career, he never would have seen a cancer patient under the age of 50. But these days, he sees it all the time.

Yeah, it's definitely something that's built slowly over time. I talked to a guy at Georgetown named John Marshall, and he's been in this field for decades, and he said at the beginning of his career, he never would have seen a cancer patient under the age of 50. But these days, he sees it all the time.

And the way he put it to me is that at least anecdotally, people who practice cancer medicine, who treat cancer patients, it's like everybody kind of started to notice at the same time about a decade ago, like, huh, it seems like I'm starting to get more interested. and more young people coming in with more advanced cancers and more aggressive cancers.

And the way he put it to me is that at least anecdotally, people who practice cancer medicine, who treat cancer patients, it's like everybody kind of started to notice at the same time about a decade ago, like, huh, it seems like I'm starting to get more interested. and more young people coming in with more advanced cancers and more aggressive cancers.